LONG-TERM SAFETY OF CANAKINUMAB IN AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES-48-MONTH DATA FROM THE RELIANCE REGISTRY

被引：0

作者：

Kuemmerle-Deschner, J. B. ^{[1
,2
]}

Henes, J. ^{[3
]}

Kortus-Goetze, B. ^{[4
]}

Oommen, P. ^{[5
]}

Pankow, A. ^{[6
]}

Kallinich, T. ^{[7
,8
]}

Krickau, T. ^{[9
]}

Schuetz, C. ^{[10
]}

Horneff, G. ^{[11
,12
]}

Foeldvari, I. ^{[13
]}

Rech, J. ^{[14
,15
,16
]}

Weller-Heinemann, F. ^{[17
]}

Janda, A. ^{[18
]}

Hufnagel, M. ^{[19
]}

Meier, F. ^{[20
,21
,22
]}

Dressler, F. ^{[23
]}

Borte, M. ^{[24
]}

Andreica, I. ^{[25
]}

Wasiliew, P. ^{[1
,2
]}

Fiene, M. ^{[26
]}

Windschall, D. ^{[27
]}

Weber-Arden, J.

Blank, N. ^{[28
]}

机构：

[1] Univ Hosp Tuebingen, Div Pediat Rheumatol, Tubingen, Germany

[2] Univ Hosp Tuebingen, Autoinflammat Reference Ctr Tuebingen, Dept Pediat, Tubingen, Germany

[3] Univ Hosp Tuebingen, Ctr Interdisciplinary Rheumatol Immunol & Autoimm, Tubingen, Germany

[4] Univ Hosp Giessen & Marburg, Dept Internal Med, Div Nephrol, Marburg, Germany

[5] Heinrich Heine Univ Duesseldorf, Dept Pediat Oncol Hematol & Clin Immunol, Ctr Child & Adolescent Hlth, Fac Med, Dusseldorf, Germany

[6] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany

[7] Charite Univ Med Berlin, Dept Pediat Resp Med Immunol & Crit Care Med, Berlin, Germany

[8] Deutsch Rheuma Forschungszentrum DRFZ, Inst Leibniz Assoc, Berlin, Germany

[9] Friedrich Alexander Univ Erlangen Nuernberg FAU, Pediat, Erlangen, Germany

[10] Tech Univ Dresden, Dept Paediat, Univ Hosp Carl Gustav Carus, Dresden, Germany

[11] Asklepios Kinderklin Sankt Augustin, Dept Pediat, St Augustin, Germany

[12] Univ Hosp Cologne, Fac Med, Dept Pediat & Adolescent Med, Cologne, Germany

[13] Hamburg Ctr Pediat & Adolescence Rheumatol, Pediat & Adolescence Rheumatol, Hamburg, Germany

[14] Ctr Rare Dis Erlangen ZSEER, Erlangen, Germany

[15] Deutsches Zentrum Immuntherapie DZI, Erlangen, Germany

[16] Univ Hosp Erlangen, Dept Rheumatol & Immunol, Erlangen, Germany

[17] Prof Hess Childrens Hosp, Div Pediat Rheumatol, Bremen, Germany

[18] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany

[19] Univ Freiburg, Fac Med, Univ Med Ctr, Div Pediat Infect Dis & Rheumatol,Dept Pediat & A, Freiburg, Germany

[20] Fraunhofer Inst Translat Med & Pharmacol ITMP, Translat Med & Pharmacol, Frankfurt, Germany

[21] Goethe Univ Hosp, Frankfurt, Germany

[22] Goethe Univ Frankfurt, Dept Gen Pharmacol & Toxicol, Frankfurt, Germany

[23] Hannover Med Sch, Childrens Hosp, Dept Paediat Pneumol Allergol & Neonatol, Hannover, Germany

[24] Univ Leipzig, Hosp Children Adolescents, St Georg Hosp, Acad Teaching Hosp, Leipzig, Germany

[25] Ruhr Univ Bochum, Rheumazentrum, Ruhrgebiet Herne, Germany

[26] Rheumatol Ctr Greifswald, Rheumatol, Greifswald, Germany

[27] Northwest German Ctr Rheumatol, St Josef Stift Sendenhorst, Clin Paediat & Adolescent Rheumatol, Sendenhorst, Germany

[28] Heidelberg Univ Hosp, Div Rheumatol, Dept Internal Med, Heidelberg, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

Innate immunity; Real-world evidence; Rare/orphan diseases;

D O I：

10.1136/annrheumdis-2023-eular.5888

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS1558

引用

页码：1153 / 1153

页数：1

共 50 条

[21] 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry
Kuemmerle-Deschner, Jasmin B.
Kortus-Goetze, Birgit
Oommen, Prasad T.
Janda, Ales
Rech, Juergen
Schuetz, Catharina
Kallinich, Tilmann
Weller-Heinemann, Frank
Horneff, Gerd
Foeldvari, Ivan
Meier, Florian
Borte, Michael
Krickau, Tobias
Weber-Arden, Julia
Blank, Norbert
[J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1613 - 1614
[22] LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN AID - INTERIM ANALYSIS OF THE CAPS SUBGROUP FROM THE RELIANCE REGISTRY
Blank, N.
Borte, M.
Foeldvari, I.
Horneff, G.
Kallinich, T.
Kortus-Goetze, B.
Oommen, P.
Schuetz, C.
Weller-Heinemann, F.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1207 - 1207
[23] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
Blank, N.
Schuetz, C.
Hufnagel, M.
Horneff, G.
Borte, M.
Kallinich, T.
Oommen, P.
Janda, A.
Henes, J.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1162 - 1163
[24] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
Blank, N.
Henes, J.
Kallinich, T.
Oommen, P.
Schuetz, C.
Borte, M.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 972 - 973
[25] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
Blank, N.
Schuetz, C.
Henes, J.
Kallinich, T.
Oommen, P.
Borte, M.
Hufnagel, M.
Janda, A.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 347 - 347
[26] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
Oommen, P.
Kallinich, T.
Rech, J.
Blank, N.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1027 - 1028
[27] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
Oommen, P.
Kallinich, T.
Rech, J.
Blank, N.
Weber-Arden, J.
Kuemmerle-Deschner, J. B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1978 - 1978
[28] Higher Rates of Disease Control During the Coronavirus Pandemic in Pediatric Patients with Autoinflammatory Periodic Diseases on Canakinumab Treatment - Interim Data from the RELIANCE Registry
Horneff, Gerd
Blank, Norbert
Kuemmerle-Deschner, Jasmin B.
Henes, Joerg
Kortus-Goetze, Birgit
Oommen, Prasad T.
Pankow, Anne
Krickau, Tobias
Schuetz, Catharina
Foeldvari, Ivan
Rech, Juergen
Weller-Heinemann, Frank
Janda, Ales
Hufnagel, Markus
Meier, Florian M.
Dressler, Frank
Borte, Michael
Andreica, Ioana
Wasiliew, Peter
Fiene, Michael
Windschall, Daniel
Krusche, Martin
Kuempfel, Tania
Weber-Arden, Julia
Kallinich, Tilmann
[J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3836 - 3839
[29] Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry
Walker, Ulrich A.
Tilson, Hugh H.
Hawkins, Philip N.
van der Poll, Tom
Noviello, Stephanie
Levy, Jeremy
Vritzali, Eleni
Hoffman, Hal M.
Kuemmerle-Deschner, Jasmin B.
[J]. RMD OPEN, 2021, 7 (02):
[30] Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients
Gulez, Nesrin
Makay, Balahan
Sozeri, Betul
[J]. MODERN RHEUMATOLOGY, 2020, 30 (01) : 166 - 171

← 1 2 3 4 5 →